$5 million funds innovation of more-potent opioid overdose antidote – WashU Medicine
NIH funding aims to accelerate drug development timeline for enhanced version of naloxone| WashU Medicine
NIH funding aims to accelerate drug development timeline for enhanced version of naloxone| WashU Medicine
Thomas Burris, Ph.D., will lead the new UF Genetics Training Program supported by a T32 grant from the National Institute of General Medical Sciences.| pharmacy.ufl.edu
The new name better reflects the department’s research scope and strengthens its efforts to recruit graduate students and postdoctoral fellows.| pharmacy.ufl.edu
In a study published in Science Advances, UF College of Pharmacy researchers found key differences in the brain’s response to stress, unlocking the potential for personalized treatments for anxiety, depression, and stress-related disorders.| pharmacy.ufl.edu
Burris was honored for his development of an exercise mimetic derived from a natural product source.| pharmacy.ufl.edu
Researchers have designed a new opioid that could provide pain relief with fewer side effects — most notably those linked to fatal overdoses.| American Chemical Society
